Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct effects of IPSU and suvorexant on mouse sleep architecture
Daniël Hoyer, Thomas Dürst, Markus Fendt, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep
Kai Liu, Juhyun Kim, Dong Won Kim, et al.
Nature (2017) Vol. 548, Iss. 7669, pp. 582-587
Open Access | Times Cited: 204
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama, Hiromitsu Tabata
Sleep Medicine Reviews (2016) Vol. 35, pp. 1-7
Closed Access | Times Cited: 133
Hypocretin underlies the evolution of sleep loss in the Mexican cavefish
James B. Jaggard, Bethany A. Stahl, Evan Lloyd, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 111
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
The roles of orexins in sleep/wake regulation
Michihiro Mieda
Neuroscience Research (2017) Vol. 118, pp. 56-65
Open Access | Times Cited: 73
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 72
Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi‐Bin Li, Jeff R. Jones, Luı́s de Lecea
Current Psychiatry Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 60
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Anthony L. Gotter, Susan L. Garson, Joanne Stevens, et al.
BMC Neuroscience (2014) Vol. 15, Iss. 1
Open Access | Times Cited: 42
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss, John Gatfield, Christine Brotschi, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2286-2305
Closed Access | Times Cited: 37
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Hypnotics with novel modes of action
Daniël Hoyer, Andrew G. Allen, Laura H. Jacobson
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 2, pp. 244-249
Open Access | Times Cited: 33
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 35
Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease
Anupam Hazra, Brian F. Corbett, Jason C. You, et al.
Neurobiology of Aging (2016) Vol. 44, pp. 96-107
Open Access | Times Cited: 29
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal
Manuel Sánchez-Alavez, Jessica Benedict, Derek N. Wills, et al.
SLEEP (2019) Vol. 42, Iss. 4
Open Access | Times Cited: 22
Manipulation of rapid eye movement sleep via orexin and GABAA receptor modulators differentially affects fear extinction in mice: effect of stable versus disrupted circadian rhythm
Jacob Clark, Heather Daykin, Jeremy A. Metha, et al.
SLEEP (2021) Vol. 44, Iss. 9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top